2-165164383-G-A

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_006922.4(SCN3A):​c.602+9C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.153 in 1,613,110 control chromosomes in the GnomAD database, including 26,558 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.23 ( 5076 hom., cov: 32)
Exomes 𝑓: 0.15 ( 21482 hom. )

Consequence

SCN3A
NM_006922.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 0.134
Variant links:
Genes affected
SCN3A (HGNC:10590): (sodium voltage-gated channel alpha subunit 3) Voltage-gated sodium channels are transmembrane glycoprotein complexes composed of a large alpha subunit with 24 transmembrane domains and one or more regulatory beta subunits. They are responsible for the generation and propagation of action potentials in neurons and muscle. This gene encodes one member of the sodium channel alpha subunit gene family, and is found in a cluster of five alpha subunit genes on chromosome 2. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant 2-165164383-G-A is Benign according to our data. Variant chr2-165164383-G-A is described in ClinVar as [Benign]. Clinvar id is 586504.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.505 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
SCN3ANM_006922.4 linkuse as main transcriptc.602+9C>T intron_variant ENST00000283254.12 NP_008853.3

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
SCN3AENST00000283254.12 linkuse as main transcriptc.602+9C>T intron_variant 1 NM_006922.4 ENSP00000283254 P1Q9NY46-3

Frequencies

GnomAD3 genomes
AF:
0.226
AC:
34267
AN:
151794
Hom.:
5051
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.361
Gnomad AMI
AF:
0.175
Gnomad AMR
AF:
0.286
Gnomad ASJ
AF:
0.130
Gnomad EAS
AF:
0.521
Gnomad SAS
AF:
0.191
Gnomad FIN
AF:
0.232
Gnomad MID
AF:
0.152
Gnomad NFE
AF:
0.115
Gnomad OTH
AF:
0.218
GnomAD3 exomes
AF:
0.219
AC:
54929
AN:
251052
Hom.:
8344
AF XY:
0.205
AC XY:
27886
AN XY:
135702
show subpopulations
Gnomad AFR exome
AF:
0.370
Gnomad AMR exome
AF:
0.373
Gnomad ASJ exome
AF:
0.134
Gnomad EAS exome
AF:
0.535
Gnomad SAS exome
AF:
0.186
Gnomad FIN exome
AF:
0.228
Gnomad NFE exome
AF:
0.116
Gnomad OTH exome
AF:
0.182
GnomAD4 exome
AF:
0.146
AC:
213102
AN:
1461198
Hom.:
21482
Cov.:
33
AF XY:
0.145
AC XY:
105536
AN XY:
726914
show subpopulations
Gnomad4 AFR exome
AF:
0.369
Gnomad4 AMR exome
AF:
0.359
Gnomad4 ASJ exome
AF:
0.130
Gnomad4 EAS exome
AF:
0.484
Gnomad4 SAS exome
AF:
0.186
Gnomad4 FIN exome
AF:
0.227
Gnomad4 NFE exome
AF:
0.110
Gnomad4 OTH exome
AF:
0.176
GnomAD4 genome
AF:
0.226
AC:
34339
AN:
151912
Hom.:
5076
Cov.:
32
AF XY:
0.232
AC XY:
17252
AN XY:
74218
show subpopulations
Gnomad4 AFR
AF:
0.361
Gnomad4 AMR
AF:
0.287
Gnomad4 ASJ
AF:
0.130
Gnomad4 EAS
AF:
0.521
Gnomad4 SAS
AF:
0.191
Gnomad4 FIN
AF:
0.232
Gnomad4 NFE
AF:
0.115
Gnomad4 OTH
AF:
0.228
Alfa
AF:
0.137
Hom.:
4054
Bravo
AF:
0.242
Asia WGS
AF:
0.370
AC:
1282
AN:
3478
EpiCase
AF:
0.108
EpiControl
AF:
0.105

ClinVar

Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Benign, criteria provided, single submitterclinical testingGeneDxMay 15, 2021- -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsApr 20, 2017- -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
not specified Benign:1
Benign, criteria provided, single submitterclinical testingUnidad de Genómica Garrahan, Hospital de Pediatría GarrahanJul 15, 2024This variant is classified as Benign based on local population frequency. This variant was detected in 35% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy and Progressive Myoclonus Epilepsy. Number of patients: 33. Only high quality variants are reported. -
Epilepsy, familial focal, with variable foci 4 Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJul 15, 2021- -
Developmental and epileptic encephalopathy, 62 Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJul 15, 2021- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.78
CADD
Benign
12
DANN
Benign
0.75

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs7579000; hg19: chr2-166020893; COSMIC: COSV51810245; COSMIC: COSV51810245; API